ReShape Lifesciences Statistics
Total Valuation
RSLS has a market cap or net worth of $798,202. The enterprise value is $246,202.
Important Dates
The next estimated earnings date is Monday, March 31, 2025, before market open.
| Earnings Date | Mar 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
RSLS has 712,680 shares outstanding. The number of shares has increased by 949.79% in one year.
| Current Share Class | 712,680 |
| Shares Outstanding | 712,680 |
| Shares Change (YoY) | +949.79% |
| Shares Change (QoQ) | +17.01% |
| Owned by Insiders (%) | 5.31% |
| Owned by Institutions (%) | 4.15% |
| Float | 674,865 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.06 |
| Forward PS | 0.25 |
| PB Ratio | 0.53 |
| P/TBV Ratio | 0.54 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.03 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.33, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.33 |
| Quick Ratio | 0.52 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -309.28% and return on invested capital (ROIC) is -196.22%.
| Return on Equity (ROE) | -309.28% |
| Return on Assets (ROA) | -73.66% |
| Return on Invested Capital (ROIC) | -196.22% |
| Return on Capital Employed (ROCE) | -498.18% |
| Revenue Per Employee | $282,172 |
| Profits Per Employee | -$243,690 |
| Employee Count | 29 |
| Asset Turnover | 1.22 |
| Inventory Turnover | 0.85 |
Taxes
In the past 12 months, RSLS has paid $65,000 in taxes.
| Income Tax | 65,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.35% in the last 52 weeks. The beta is 1.44, so RSLS's price volatility has been higher than the market average.
| Beta (5Y) | 1.44 |
| 52-Week Price Change | -88.35% |
| 50-Day Moving Average | 3.94 |
| 200-Day Moving Average | 7.78 |
| Relative Strength Index (RSI) | 19.11 |
| Average Volume (20 Days) | 2,593,516 |
Short Selling Information
The latest short interest is 22,551, so 3.16% of the outstanding shares have been sold short.
| Short Interest | 22,551 |
| Short Previous Month | 16,142 |
| Short % of Shares Out | 3.16% |
| Short % of Float | 3.34% |
| Short Ratio (days to cover) | 0.22 |
Income Statement
In the last 12 months, RSLS had revenue of $8.18 million and -$7.07 million in losses. Loss per share was -$17.51.
| Revenue | 8.18M |
| Gross Profit | 5.58M |
| Operating Income | -7.92M |
| Pretax Income | -10.87M |
| Net Income | -7.07M |
| EBITDA | -7.90M |
| EBIT | -7.92M |
| Loss Per Share | -$17.51 |
Full Income StatementBalance Sheet
The company has $743,000 in cash and $191,000 in debt, giving a net cash position of $552,000 or $0.77 per share.
| Cash & Cash Equivalents | 743,000 |
| Total Debt | 191,000 |
| Net Cash | 552,000 |
| Net Cash Per Share | $0.77 |
| Equity (Book Value) | 1.49M |
| Book Value Per Share | 2.11 |
| Working Capital | 1.31M |
Full Balance SheetCash Flow
| Operating Cash Flow | -6.20M |
| Capital Expenditures | n/a |
| Free Cash Flow | -6.20M |
| FCF Per Share | -$8.70 |
Full Cash Flow StatementMargins
Gross margin is 68.19%, with operating and profit margins of -96.80% and -86.36%.
| Gross Margin | 68.19% |
| Operating Margin | -96.80% |
| Pretax Margin | -85.57% |
| Profit Margin | -86.36% |
| EBITDA Margin | -96.50% |
| EBIT Margin | -96.80% |
| FCF Margin | n/a |